NASDAQ · Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc (LNTH)
$100.46
+0.14%
56
In band
Moving averages
SMA 200$89.10+12.75%
Company profile
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$6.55B
P/E ratio24.27
EPS$4.13
Beta-0.058
Dividend yield0.00%
52-week high$111.86
52-week low$50.16
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 45
CGC
Canopy Growth Corporation
RSI 25
BFRI
Biofrontera Inc
RSI 42
TLRY
Tilray Brands Inc - Class 2
RSI 18
BCRX
Biocryst Pharmaceuticals Inc
RSI 55
ACB
Aurora Cannabis Inc
RSI 50
ORGO
Organogenesis Holdings Inc - Class A
RSI 16
INM
InMed Pharmaceuticals Inc
RSI 71
RSI alerts for LNTH
An email when LNTH closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:15 PM EDT